SPECT/CT引导下选择性颈部淋巴结照射治疗头颈癌:利用NTCP模型估计临床获益
本研究纳入40例侧方cT1-3N0-2bM0头颈鳞癌患者,利用SPECT/CT淋巴引流显像筛选患者行单侧选择性淋巴结照射(ENI),并与按机构指南行双侧照射的虚拟计划比较剂量学参数,采用5个正常组织并发症概率(NTCP)模型预测临床获益。结果显示对侧腮腺、下颌下腺、声门喉、声门上喉、咽缩肌和甲状腺的中位剂量分别降低19.2、27.3、11.4、9.7、12.1和18.4 Gy,口干、对侧腮腺功能、吞咽困难、甲状腺功能减退和喉水肿的中位NTCP分别降低20%、14%、10%、20%和5%。
要点
- SPECT/CT淋巴引流显像引导的单侧ENI可显著降低对侧危及器官剂量。
- 对侧腮腺和下颌下腺中位剂量分别降低19.2 Gy和27.3 Gy。
- 口干和甲状腺功能减退的中位NTCP均降低20%。
核心结论
- 选择性SPECT/CT引导的ENI可显著降低多个危及器官的剂量及相应NTCP值,进而可能减少多种放射性毒性的发生率和严重程度并改善生活质量。
研究设计与样本
- 研究纳入40例侧方cT1-3N0-2bM0头颈鳞状细胞癌患者,先行淋巴引流显像,再比较实际治疗的计划(SPECT/CT引导的选择性计划,照射同侧颈部±任何对侧引流区)与虚拟计划(按机构指南行双侧照射的标准计划)的剂量学差异,并使用5个NTCP模型预测临床获益。
主要发现
- 对侧腮腺、对侧下颌下腺、声门喉、声门上喉、咽缩肌和甲状腺的中位剂量分别降低19.2、27.3、11.4、9.7、12.1和18.4 Gy。
- 口干、对侧腮腺功能、吞咽困难、甲状腺功能减退和喉水肿的中位NTCP分别降低20%、14%、10%、20%和5%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The great majority of patients with lateralized head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy routinely undergo bilateral elective nodal irradiation (ENI), even though the incidence of contralateral regional failure after unilateral ENI is low. Excluding the contralateral neck from elective irradiation could reduce radiation-related toxicity and improve quality-of-life. The current study investigated the dosimetric benefits of a novel approach using lymph drainage mapping by SPECT/CT to select patients for unilateral ENI. PATIENTS AND METHODS: Forty patients with lateralized cT1-3N0-2bM0 HNSCC underwent lymph drainage mapping. Two radiation plans were made; the real plan with which patients were actually treated (selective SPECT/CT-guided plan irradiating the ipsilateral neck ± any contralateral draining level); and the virtual plan (standard plan according to institutional guidelines, as if the same patient would have been treated bilaterally). Radiation doses to clinically important organs-at-risk were compared between the two plans. We used five normal tissue complication probability (NTCP) models to predict the clinical benefits of this approach. RESULTS: Median dose reductions to the contralateral parotid gland, contralateral submandibular gland, glottic larynx, supraglottic larynx, constrictor muscle and thyroid gland were 19.2, 27.3, 11.4, 9.7, 12.1 and 18.4 Gy, respectively. Median NTCP reductions for xerostomia, contralateral parotid function, dysphagia, hypothyroidism and laryngeal edema were 20%, 14%, 10%, 20% and 5% respectively. CONCLUSIONS: Selective SPECT/CT-guided ENI results in significant dose reductions to various organs-at-risk and corresponding NTCP values, and will subsequently reduce the incidence and severity of different troublesome radiation-related toxicities and improve quality-of-life.
引用
- de Veij Mestdagh PD, Janssen T, Lamers E, et al. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models. Radiother Oncol. 2018. PMID: 30087057. doi:10.1016/j.radonc.2018.07.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。